Skip to main content

Peer Review reports

From: Treatment of three pediatric AML co-expressing NUP98-NSD1, FLT3-ITD, and WT1

Original Submission
30 Nov 2023 Submitted Original manuscript
10 Jan 2024 Reviewed Reviewer Report
14 Jan 2024 Reviewed Reviewer Report - Shohei Yamamoto
28 Jan 2024 Author responded Author comments - Xin Tian
Resubmission - Version 2
28 Jan 2024 Submitted Manuscript version 2
14 Feb 2024 Reviewed Reviewer Report
15 Feb 2024 Reviewed Reviewer Report - Shohei Yamamoto
7 Mar 2024 Author responded Author comments - Xin Tian
Resubmission - Version 3
7 Mar 2024 Submitted Manuscript version 3
11 Mar 2024 Author responded Author comments - Xin Tian
Resubmission - Version 4
11 Mar 2024 Submitted Manuscript version 4
12 Mar 2024 Author responded Author comments - Xin Tian
Resubmission - Version 5
12 Mar 2024 Submitted Manuscript version 5
16 Apr 2024 Reviewed Reviewer Report
7 Jun 2024 Author responded Author comments - Xin Tian
Resubmission - Version 6
7 Jun 2024 Submitted Manuscript version 6
15 Jun 2024 Author responded Author comments - Xin Tian
Resubmission - Version 7
15 Jun 2024 Submitted Manuscript version 7
24 Jun 2024 Author responded Author comments - Xin Tian
Resubmission - Version 8
24 Jun 2024 Submitted Manuscript version 8
29 Jun 2024 Author responded Author comments - Xin Tian
Resubmission - Version 9
29 Jun 2024 Submitted Manuscript version 9
16 Jul 2024 Author responded Author comments - Xin Tian
Resubmission - Version 10
16 Jul 2024 Submitted Manuscript version 10
Publishing
17 Jul 2024 Editorially accepted
27 Jul 2024 Article published 10.1186/s12887-024-04954-1

You can find further information about peer review here.

Back to article page